Mast cell leukemia surgery: Difference between revisions
Jump to navigation
Jump to search
Nawal Muazam (talk | contribs) No edit summary |
Farima Kahe (talk | contribs) No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{NM}} | {{CMG}}; {{AE}} {{NM}} | ||
==Overview== | ==Overview== | ||
The predominant therapy for mast cell leukemia is immunochemotherapy. Surgical management, such as [[splenectomy]] or [[bone marrow transplantation]] may be required in certain cases. | The predominant therapy for mast cell leukemia is immunochemotherapy. Surgical management, such as [[splenectomy]] or [[bone marrow transplantation]] may be required in certain cases. | ||
==Surgery== | ==Surgery== | ||
The predominant therapy for mast cell leukemia is immunochemotherapy. Surgical management, such as [[splenectomy]] or [[bone marrow transplantation]] may be required in certain cases.<ref name="Georgin-LavialleLhermitte2012">{{cite journal|last1=Georgin-Lavialle|first1=S.|last2=Lhermitte|first2=L.|last3=Dubreuil|first3=P.|last4=Chandesris|first4=M.-O.|last5=Hermine|first5=O.|last6=Damaj|first6=G.|title=Mast cell leukemia|journal=Blood|volume=121|issue=8|year=2012|pages=1285–1295|issn=0006-4971|doi=10.1182/blood-2012-07-442400}}</ref> | The predominant therapy for mast cell leukemia is immunochemotherapy. Surgical management, such as [[splenectomy]] or [[bone marrow transplantation]] may be required in certain cases.<ref name="Georgin-LavialleLhermitte2012">{{cite journal|last1=Georgin-Lavialle|first1=S.|last2=Lhermitte|first2=L.|last3=Dubreuil|first3=P.|last4=Chandesris|first4=M.-O.|last5=Hermine|first5=O.|last6=Damaj|first6=G.|title=Mast cell leukemia|journal=Blood|volume=121|issue=8|year=2012|pages=1285–1295|issn=0006-4971|doi=10.1182/blood-2012-07-442400}}</ref> | ||
Latest revision as of 15:57, 8 November 2018
|
Mast cell leukemia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Mast cell leukemia surgery On the Web |
|
American Roentgen Ray Society Images of Mast cell leukemia surgery |
|
Risk calculators and risk factors for Mast cell leukemia surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]
Overview
The predominant therapy for mast cell leukemia is immunochemotherapy. Surgical management, such as splenectomy or bone marrow transplantation may be required in certain cases.
Surgery
The predominant therapy for mast cell leukemia is immunochemotherapy. Surgical management, such as splenectomy or bone marrow transplantation may be required in certain cases.[1]
References
- ↑ Georgin-Lavialle, S.; Lhermitte, L.; Dubreuil, P.; Chandesris, M.-O.; Hermine, O.; Damaj, G. (2012). "Mast cell leukemia". Blood. 121 (8): 1285–1295. doi:10.1182/blood-2012-07-442400. ISSN 0006-4971.